×

BRIEF-Vanda Pharmaceuticals says received notice from Novartis Pharma Ag

Oct 10 (Reuters) - Vanda Pharmaceuticals Inc :

* On October 8, 2012, Vanda Pharmaceuticals received written notice from

Novartis Pharma Ag

* Notice determined to cease the development of the long-acting injectable

formulation of iloperidone * Source text ( ) * Further company coverage ((Bangalore Newsroom; +1 646 223 8780))